Page last updated: 2024-09-03

thrombin receptor peptide sfllrnp and Coronary Disease

thrombin receptor peptide sfllrnp has been researched along with Coronary Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bobbert, P; Bobbert, T; Rauch, U; Schultheiss, HP; Schütte, C; Steffens, D; Stellbaum, C1
Duffy, SJ; Holbrook, M; Keaney, JF; Swerdloff, PL; Vita, JA1

Trials

1 trial(s) available for thrombin receptor peptide sfllrnp and Coronary Disease

ArticleYear
Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease.
    Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:6

    Topics: Adenosine Diphosphate; Coronary Artery Disease; Coronary Disease; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Humans; Lipids; Male; Middle Aged; Peptide Fragments; Platelet Aggregation; Tea

2001

Other Studies

1 other study(ies) available for thrombin receptor peptide sfllrnp and Coronary Disease

ArticleYear
Postmenopausal women have an increased maximal platelet reactivity compared to men despite dual antiplatelet therapy.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2012, Volume: 23, Issue:8

    Topics: Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; Blood Platelets; Clopidogrel; Coronary Disease; Female; Humans; Male; Middle Aged; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Postmenopause; Prospective Studies; Sex Factors; Ticlopidine

2012